PUM1
OFFICE ACTION ISSUED POU1
04/21/2026
Back to search
Official data from USPTO
CRISPR THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
04/22/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
04/11/2018
Registration date
05/12/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2020
Last transaction
04/22/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
07/22/2019
First use in commerce
07/22/2019
Drawing code
3
Owner type
99
Owner location
ZUG V8, CH
Examiner
SCHIMPF, TIMOTHY O
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an incomplete square with a break in the lower right of the square. At the bottom of the square below the break appears a shaded rectangle. In the lower middle of the square appears the stylized word "CRISPR" with the second "R" connected to the square. In the shaded rectangle appears the stylized word "THERAPEUTICS".
Holders and representatives
Holders
CRISPR Therapeutics AG
CRISPR Therapeutics AG
Representatives
Tiffany D. Gehrke Marshall Gerstein & Borun LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancerinfectious diseaseautoimmune disorderstransplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancerinfectious diseaseautoimmune disorderstransplant rejections and inflammatory disease; pharmaceutical products and preparationsgene transferregulationmodulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
Publications
History of USPTO decisions and trademark events.
55 publications found
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/15/2026
ES8R
TEAS SECTION 8 RECEIVED
03/17/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/28/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/28/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/28/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/28/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/28/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/07/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/07/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/07/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/07/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/05/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/05/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/05/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/05/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/05/2020
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/12/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/09/2020
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
04/02/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04/01/2020
IUAA
USE AMENDMENT ACCEPTED
04/01/2020
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
03/27/2020
IUAF
USE AMENDMENT FILED
03/27/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2020
EAAU
TEAS AMENDMENT OF USE RECEIVED
03/25/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/25/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/27/2019
GNRT
NON-FINAL ACTION E-MAILED
09/27/2019
CNRT
NON-FINAL ACTION WRITTEN
09/27/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/17/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/17/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/13/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/26/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/26/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/13/2019
GNRT
NON-FINAL ACTION E-MAILED
03/13/2019
CNRT
NON-FINAL ACTION WRITTEN
03/13/2019
DPCC
DIVISIONAL PROCESSING COMPLETE
02/21/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/13/2019
ALIE
ASSIGNED TO LIE
02/12/2019
DRRR
DIVISIONAL REQUEST RECEIVED
02/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
02/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/07/2018
GNRT
NON-FINAL ACTION E-MAILED
08/07/2018
CNRT
NON-FINAL ACTION WRITTEN
08/07/2018
DOCK
ASSIGNED TO EXAMINER
07/31/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/20/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/19/2018
Continuous trademark protection
Get notified about every new filing that threatens CRISPR THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.